INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 359 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.

Quarter-by-quarter ownership
INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$33,067
+10.6%
7290.0%0.01%0.0%
Q2 2023$29,911
+13.7%
729
-1.0%
0.01%
+25.0%
Q1 2023$26,305
-10.0%
736
-4.9%
0.00%
-20.0%
Q4 2022$29,234
-16.5%
774
-1.5%
0.01%
-16.7%
Q3 2022$35,000
+25.0%
786
+5.4%
0.01%
+20.0%
Q2 2022$28,0000.0%7460.0%0.01%
+25.0%
Q1 2022$28,000
+21.7%
746
-2.5%
0.00%0.0%
Q4 2021$23,000
-11.5%
7650.0%0.00%0.0%
Q3 2021$26,000
-16.1%
7650.0%0.00%
-20.0%
Q2 2021$31,000
-8.8%
7650.0%0.01%
-28.6%
Q1 2021$34,000
-41.4%
765
-24.9%
0.01%
-41.7%
Q4 2020$58,000
+20.8%
1,0190.0%0.01%
+9.1%
Q3 2020$48,000
-20.0%
1,0190.0%0.01%
-8.3%
Q2 2020$60,000
+22.4%
1,019
-1.3%
0.01%
+9.1%
Q1 2020$49,000
-21.0%
1,0320.0%0.01%
-15.4%
Q4 2019$62,0000.0%1,032
-0.4%
0.01%
-7.1%
Q3 2019$62,000
-6.1%
1,036
+0.3%
0.01%0.0%
Q2 2019$66,000
-17.5%
1,033
+5.4%
0.01%
-17.6%
Q1 2019$80,000
+45.5%
980
-3.6%
0.02%
+41.7%
Q4 2018$55,000
+5.8%
1,0170.0%0.01%
+20.0%
Q3 2018$52,000
+23.8%
1,0170.0%0.01%
+11.1%
Q2 2018$42,000
-6.7%
1,0170.0%0.01%
-10.0%
Q1 2018$45,0001,0170.01%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Bellevue Group AG 9,930,245$396,117,0003.87%
Sicart Associates LLC 368,409$14,696,0003.50%
Camber Capital Management LP 2,000,000$79,780,0002.69%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 181,781$7,251,0001.91%
SECTOR GAMMA AS 263,488$10,511,0001.86%
Parkman Healthcare Partners LLC 136,380$5,440,0001.19%
Eversept Partners, LP 442,000$17,631,3801.18%
Affinity Asset Advisors, LLC 75,000$2,992,0001.07%
TANAKA CAPITAL MANAGEMENT INC 16,661$665,0000.90%
Sonora Investment Management, LLC 168,665$6,728,0000.88%
View complete list of IONIS PHARMACEUTICALS INC shareholders